Source: PR Newswire

Press Release: Cygnus Technologies, Inc. : BIO-TECHNE AND CYGNUS TECHNOLOGIES, PART OF MARAVAI LIFESCIENCES, INTRODUCE NEW SIMPLE PLEX HEK 293 HCP 3G IMMUNOASSAY

/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) and Cygnus Technologies, part of Maravai LifeSciences (NASDAQ: MRVI), announced today the launch of the...

Read full article »
Cygnus Technologies, Inc.'s Competitors | Cygnus Technologies, Inc.'s News | Cygnus Technologies, Inc.'s Financials
Stay up-to-date with the latest news on Cygnus Technologies, Inc.
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Read more
Stay up-to-date with the latest news on Cygnus Technologies, Inc.